Compounds > 2-chloroadenosine
Page last updated: 2024-08-20

2-chloroadenosine and Cancer of Spleen

2-chloroadenosine has been researched along with Cancer of Spleen in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buda, G; Cecconi, N; Cervetti, G; Galimberti, S; Orciuolo, E; Petrini, M; Sordi, E1
Caracciolo, F; Cecconi, N; Galimberti, S; Petrini, M; Riccioni, R1
Mehta, A; Virchis, A1

Other Studies

3 other study(ies) available for 2-chloroadenosine and Cancer of Spleen

ArticleYear
Significant efficacy of 2-CdA with or without rituximab in the treatment of splenic marginal zone lymphoma (SMZL).
    Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:4

    Topics: 2-Chloroadenosine; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Deoxyadenosines; Disease-Free Survival; Female; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Remission Induction; Retrospective Studies; Rituximab; Splenic Neoplasms; Treatment Outcome

2010
Low dose 2-CdA schedule activity in splenic marginal zone lymphomas.
    Hematological oncology, 2003, Volume: 21, Issue:4

    Topics: 2-Chloroadenosine; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Deoxyadenosines; Female; Humans; Lymphoma; Middle Aged; Splenectomy; Splenic Neoplasms; Survival Analysis; Treatment Outcome

2003
Splenic lymphoma with villous lymphocytes (SLVL) responding to 2-chlorodeoxyadenosine (2-CdA)
    British journal of haematology, 1998, Volume: 100, Issue:3

    Topics: 2-Chloroadenosine; Antimetabolites, Antineoplastic; Deoxyadenosines; Humans; Lymphoma; Splenectomy; Splenic Neoplasms

1998